News

MediGene AG divests Oncolytic Herpes Simplex Viruses (oHSV) program to Catherex, Inc.

SHOW RELEASE

MediGene Signs Agreement with Meditrina for the Commercialization of Veregen® in Greece and Cyprus

SHOW RELEASE

MediGene appoints Arnd Christ as Chief Financial Officeras Successor to Dr. Thomas Klaue

SHOW RELEASE

MediGene AG Reports Financial Results for the 2009 Fiscal Year

SHOW RELEASE

MediGene's Veregen® launched by Solvay in Germany

SHOW RELEASE

MediGene and Teva sign agreement to commercialize Veregen(TM) in Israel

SHOW RELEASE

MediGene nominates Dr. Thomas Werner to the Supervisory Board

SHOW RELEASE